Genome Sequence of the Melanin-Producing Extremophile Aeromonas salmonicida subsp. pectinolytica Strain 34melT [PDF]
, 2016 open5siThe genome of Aeromonas salmonicida subsp. pectinolytica strain 34melT, isolated from a heavily polluted river, contains several genomic islands and putative virulence genes. The identification of genes involved in resistance to different kinds of
Levin, Laura Noemí +4 more
core +4 more sources
Association of Type III secretion genes with virulence of Aeromonas salmonicida subsp. salmonicida [PDF]
Diseases of Aquatic Organisms, 2003 Aeromonas salmonicida subsp. salmonicida possesses a number of potential virulence factors, including a recently identified plasmid-encoded Type III secretion system. A number of field isolates of A. salmonicida subsp. salmonicida were examined for the presence of Type III secretion genes.
Burr SE +4 more
openaire +3 more sources
Ribotyping of Aeromonas salmonicida subsp. salmonicida
Diseases of Aquatic Organisms, 1994 A collection of 124 strains of the bacterial fish pathogen Aeromonas salmonicjda subsp, salmonicida isolated from diseased salmonids in Denmark (n = 57), Norway (n = 28), Scotland (n = 20), and North America (n = 19) was characterized by ribotyping. For reference, the type strain NCMB 1102 was likewise examined.
Nielsen, B., Olsen, J. E., Larsen, J. L.
openaire +2 more sources
Microorganisms, 2022 Aeromonas salmonicida is a global distributed Gram-negative teleost pathogen, affecting mainly salmonids in fresh and marine environments. A. salmonicida strains are classified as typical or atypical depending on their origin of isolation and phenotype ...
Ignacio Vasquez +10 more
doaj +1 more source
Antigens of Aeromonas salmonicida subsp. salmonicida specifically induced in vivo in Oncorhynchus mykiss. [PDF]
J Fish Dis, 2016 Furunculosis is a major fish disease, associated with high mortality rates, and its effect is particularly significant in farmed salmonids (Hiney & Olivier 1999). Efficacious vaccines, generally injected alongside an oil adjuvant, are available. However, certain side effects have been reported (Midtlyng, Reitan & Speilberg 1996; Anderson et al.
Menanteau-Ledouble S, El-Matbouli M.
europepmc +5 more sources
Comparative genomics of the Aeromonadaceae core oligosaccharide biosynthetic regions. [PDF]
, 2017 Lipopolysaccharides (LPSs) are an integral part of the Gram-negative outer membrane, playing important organizational and structural roles and taking part in the bacterial infection process.
Forn-Cuní, Gabriel +2 more
core +2 more sources
Divergent evolution and purifying selection of the gene sequences in [PDF]
, 2009 Background The bacterial flagellum is the most important organelle of motility in bacteria and plays a key role in many bacterial lifestyles, including virulence.
Maribel Farfán +3 more
core +5 more sources
Evidence against dormacy in the bacterial fish pathogenAeromonas salmonicidasubsp.salmonicida [PDF]
FEMS Microbiology Letters, 1990 Results indicate that A. salmonicida does not enter an unculturable dormant state. The resuscitation of dormant cells by nutrient broth described by previous workers appears to be due to the presence of small numbers of viable, culturable cells too few to be detected by the sampling protocol employed.
A S, Rose, A E, Ellis, A L, Munro
openaire +2 more sources
Antibacterial Activity of Commercial Phytochemicals against Aeromonas Species Isolated from Fish
Pathogens, 2019 Antimicrobial activities of phytochemicals—trans-cinnamaldehyde (TC), ferulic acid (FA), p-coumaric acid (p-CA), caffeic acid (CA), chlorogenic acid (CHA), Thymus vulgaris essential oil (TO), Eugenia caryophyllus essential oil (ECO), and Melaleuca ...
Barbara Kot +4 more
doaj +1 more source
The mosaic architecture of Aeromonas salmonicida subsp. salmonicida pAsa4 plasmid and its consequences on antibiotic resistance [PDF]
PeerJ, 2016 Aeromonas salmonicida subsp. salmonicida, the causative agent of furunculosis in salmonids, is an issue especially because many isolates of this bacterium display antibiotic resistances, which limit treatments against the disease.
Katherine H. Tanaka +5 more
doaj +2 more sources